Moderna's decision aligns with its broader effort to cut costs by resizing its Covid vaccine-manufacturing footprint. Read this story
Moderna's decision aligns with its broader effort to cut costs by resizing its Covid vaccine-manufacturing footprint. Read this story
More from CNBC | Business Biotechnology Biotech and Pharmaceuticals Pharmaceuticals Health care industry Moderna Inc Kenya Breaking news business news cnbc Articles US: News Companies Business News Health & Science source:tagname:CNBC US Source